| SORAFENIB TOSYLATE | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | testicular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | primary peritoneal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELVARAFENIB | Small molecule | cancer | RAF serine/threonine protein kinase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | follicular thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Enrolling by invitation | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | pancreatic adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cervical carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| TOVORAFENIB | Small molecule | low grade glioma | RAF serine/threonine protein kinase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | Keloid | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | anaplastic oligodendroglioma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | brain neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | bile duct carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thrombotic disease | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Enrolling by invitation | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | macular degeneration | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| TOVORAFENIB | Small molecule | Craniopharyngioma | RAF serine/threonine protein kinase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | biliary tract neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | renal pelvis/ureter urothelial carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| XL-281 | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | brain neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | DailyMed |
| LXH254 | Small molecule | non-small cell lung carcinoma | B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | Hepatoblastoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 0.5 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal pelvis/ureter urothelial carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | fallopian tube cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Suspended | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | acute promyelocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 0.5 | Terminated | ClinicalTrials |
| TOVORAFENIB | Small molecule | low grade glioma | RAF serine/threonine protein kinase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | myelodysplastic syndrome | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | grade III glioma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Completed | ClinicalTrials |
| TOVORAFENIB | Small molecule | Langerhans Cell Histiocytosis | RAF serine/threonine protein kinase inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | thrombotic disease | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| LXH254 | Small molecule | melanoma | B-raf/RAF proto-oncogene serine/threonine-protein kinase inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | esophageal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | thrombotic disease | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | tongue neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | mixed phenotype acute leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Suspended | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | osteosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | Mantle cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | portal hypertension | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| LY-3009120 | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | peritoneum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| XL-281 | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cholangiocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | urethra cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | nasopharyngeal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | Kaposi's sarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | multiple myeloma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | Central Nervous System Neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | follicular thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | mesothelioma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | anaplastic astrocytoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma of liver and intrahepatic biliary tract | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | ATC |
| SORAFENIB | Small molecule | myelodysplastic syndrome | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | pleomorphic rhabdomyosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | oropharyngeal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Enrolling by invitation | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | Hepatopulmonary Syndrome | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | chromophobe renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | Desmoid-type fibromatosis | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | laryngeal squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | Mantle cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| TOVORAFENIB | Small molecule | cancer | RAF serine/threonine protein kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | prostate adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | myeloid sarcoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | Uveal Melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | salivary gland squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | grade III glioma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | human herpesvirus 8 infection | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | mesothelioma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | kidney disease | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| TOVORAFENIB | Small molecule | low grade glioma | RAF serine/threonine protein kinase inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | esophageal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | Ewing sarcoma/peripheral primitive neuroectodermal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | urinary bladder carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| XL-281 | Small molecule | papillary thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | multiple myeloma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | mucosal melanoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | cholangiocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | DailyMed |
| SORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| BELVARAFENIB | Small molecule | neoplasm | RAF serine/threonine protein kinase inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hypopharyngeal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | core binding factor acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| TOVORAFENIB | Small molecule | melanoma | RAF serine/threonine protein kinase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | colon adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | DailyMed |
| SORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| XL-281 | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | adenoid cystic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | chronic myelogenous leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | verrucous carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | diffuse large B-cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | brain neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | biliary tract cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | tongue neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | urethra cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | neuroblastoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | papillary renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | Digestive System Carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | acute lymphoblastic leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | chromophobe renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 0.5 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | pancreatic adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | rectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | Uterine Carcinosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | Uterine Carcinosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | kidney neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | male breast carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | adrenal cortex carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neuroendocrine neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | papillary thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | rhabdomyosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | peritoneum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | osteosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | papillary renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | medullary thyroid gland carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal pelvis/ureter urothelial carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | papillary renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | uterine sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | oropharyngeal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid neoplasm | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| TOVORAFENIB | Small molecule | melanoma | RAF serine/threonine protein kinase inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | urinary bladder cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | small cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | medullary thyroid gland carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | osteosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | rhabdomyosarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| BELVARAFENIB | Small molecule | melanoma | RAF serine/threonine protein kinase inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | multiple myeloma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | chronic lymphocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | Central Nervous System Neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | lymphoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | rectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Suspended | ClinicalTrials |
| SORAFENIB | Small molecule | Ewing sarcoma/peripheral primitive neuroectodermal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | therapy related acute myeloid leukemia and myelodysplastic syndrome | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | fallopian tube cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | fallopian tube cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | upper aerodigestive tract neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Suspended | ClinicalTrials |
| REGORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | angiosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | acute lymphoblastic leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| ARQ-736 | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | verrucous carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | ovarian cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | nasal cavity and paranasal sinus squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | intrahepatic cholangiocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Not yet recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver disease | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | grade III glioma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | acute promyelocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Not yet recruiting | ClinicalTrials |
| LY-3009120 | Small molecule | metastasis | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | Uveal Melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | esophageal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | chronic lymphocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | ATC |
| SORAFENIB TOSYLATE | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma of liver and intrahepatic biliary tract | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hypopharyngeal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | anaplastic large cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | pleomorphic rhabdomyosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | anaplastic oligoastrocytoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | metastatic malignant neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | acute lymphoblastic leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | multiple myeloma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | anaplastic oligodendroglioma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gastric cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cervical carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | nasopharyngeal neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | Poorly Differentiated Thyroid Gland Carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma of liver and intrahepatic biliary tract | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | osteosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | rectum cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cutaneous melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | mesothelioma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | papillary thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | anaplastic astrocytoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gliosarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | salivary gland squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | prostate adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | thyroid carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | DailyMed |
| SORAFENIB TOSYLATE | Small molecule | myeloid sarcoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | acute monocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | diffuse large B-cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| TOVORAFENIB | Small molecule | metastatic melanoma | RAF serine/threonine protein kinase inhibitor | 1.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | ovarian neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | acute myeloid leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Active, not recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | kidney cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Withdrawn | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | multiple myeloma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| REGORAFENIB | Small molecule | malignant renal pelvis neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | neuroblastoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 4.0 | - | DailyMed |
| LY-3009120 | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Not yet recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | soft tissue sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | ovarian carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Active, not recruiting | ClinicalTrials |
| LY-3009120 | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | colorectal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Recruiting | ClinicalTrials |
| REGORAFENIB | Small molecule | liposarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | liver cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | male breast carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | papillary renal cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | urinary bladder carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | uterine sarcoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | mucosal melanoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | mixed phenotype acute leukemia | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Recruiting | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | nasal cavity and paranasal sinus squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | glioblastoma multiforme | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gastroesophageal junction adenocarcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | malignant colon neoplasm | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | breast cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | prostate cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| REGORAFENIB | Small molecule | small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Terminated | ClinicalTrials |
| SORAFENIB | Small molecule | anaplastic large cell lymphoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | renal pelvis/ureter urothelial carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Terminated | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | Desmoid-type fibromatosis | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Active, not recruiting | ClinicalTrials |
| SORAFENIB | Small molecule | liver neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Unknown status | ClinicalTrials |
| SORAFENIB | Small molecule | melanoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Withdrawn | ClinicalTrials |
| SORAFENIB | Small molecule | pancreatic carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | lung cancer | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | gastrointestinal stromal tumor | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| REGORAFENIB | Small molecule | metastatic colorectal cancer | Serine/threonine-protein kinase RAF inhibitor | 3.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | urinary bladder carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | acute promyelocytic leukemia | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | non-small cell lung carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | hepatocellular carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | pulmonary arterial hypertension | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | ovarian neoplasm | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |
| SORAFENIB | Small molecule | cancer | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | clear cell renal carcinoma | Serine/threonine-protein kinase RAF inhibitor | 1.0 | Completed | ClinicalTrials |
| SORAFENIB TOSYLATE | Small molecule | laryngeal squamous cell carcinoma | Serine/threonine-protein kinase RAF inhibitor | 2.0 | Completed | ClinicalTrials |